Article Information
History
- January 14, 2022.
Article Versions
- Version 1 (December 27, 2021 - 11:01).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Nigel Garrett, MBBS1,
- Asa Tapley, MD2,3,
- Jessica Andriesen, PhD2,
- Ishen Seocharan, BTech4,
- Leigh H. Fisher, PhD2,
- Lisa Bunts, BA2,
- Nicole Espy, PhD2,
- Carole L. Wallis, PhD5,
- April Kaur Randhawa, PhD2,
- Nzeera Ketter, MD2,
- Margaret Yacovone, MD6,
- Ameena Goga, MBChB4,
- Linda-Gail Bekker, MD7,
- Glenda E. Gray, MBBCh4 and
- Lawrence Corey, MD2,*
- 1Centre for the AIDS Programme of Research in South Africa, University of KwaZulu–Natal, Durban, South Africa
- 2Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 3University of Washington School of Medicine, Seattle, WA, USA
- 4South African Medical Research Council, Pretoria, South Africa
- 5Bio Analytical Research Corporation South Africa and Lancet Laboratories, Johannesburg, South Africa
- 6National Institutes of Health, Bethesda, MD, USA
- 7Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
- ↵*Corresponding author Lawrence Corey, lcorey{at}fredhutch.org
Posted January 14, 2022.
